Pilot study to identify small molecule activators of TCF4 as a treatment for Pitt-Hopkins syndrome

Awardee: Benjamin Philpot

Institution: University of North Carolina, Chapel Hill

Award Amount: $49,263

Funding Period: January 1, 2018 - December 31, 2018

Previous
Previous

Brain MRI signatures in infants with infantile forms of GM-1 and GM-2

Next
Next

The neuropathology of CDKL5 disorder